Lauren Riker Biography and Net Worth

SVP of Pacira BioSciences

Lauren Riker is the SVP of Pacira BioSciences.

What is Lauren Riker's net worth?: The estimated net worth of Lauren Riker is at least $1.58 million as of June 11th, 2026. Riker owns 62,284 shares of Pacira BioSciences stock worth more than $1,581,391 as of July 4th. This net worth approximation does not reflect any other investments that Riker may own. Learn More about Lauren Riker's net worth.
How do I contact Lauren Riker?: The corporate mailing address for Riker and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Lauren Riker's contact information.
Has Lauren Riker been buying or selling shares of Pacira BioSciences?: Lauren Riker has not been actively trading shares of Pacira BioSciences during the past quarter. Most recently, Lauren Riker sold 6,115 shares of the business's stock in a transaction on Thursday, June 11th. The shares were sold at an average price of $23.50, for a transaction totalling $143,702.50. Following the completion of the sale, the senior vice president now directly owns 62,284 shares of the company's stock, valued at $1,463,674. Learn More on Lauren Riker's trading history.
Who are Pacira BioSciences' active insiders?: Pacira BioSciences' insider roster includes Marcelo Bigal (Director), Shawn Cross (CFO), Mark Froimson (Director), Mark Kronenfeld (Director), Frank Lee (Chief Executive Officer & Director), Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), Lauren Riker (SVP), Jonathan Slonin (Chief Medical Officer), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), Kristen Williams (Chief Administrative Officer & Secretary), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.
Are insiders buying or selling shares of Pacira BioSciences?: In the last twelve months, insiders at the sold shares 13 times. They sold a total of 77,624 shares worth more than $1,897,687.61. The most recent insider tranaction occured on June, 11th when SVP Lauren Riker sold 6,115 shares worth more than $143,702.50. Insiders at Pacira BioSciences own 6.4% of the company. Learn More about insider trades at Pacira BioSciences.
Information on this page was last updated on 6/11/2026.

Lauren Riker Insider Trading History at Pacira BioSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/11/2026	Sell	6,115	$23.50	$143,702.50	62,284
2/2/2026	Sell	4,000	$20.81	$83,240.00	52,313
1/5/2026	Sell	1,416	$24.24	$34,323.84	59,064
6/4/2025	Sell	5,578	$26.21	$146,199.38	59,564
6/12/2024	Sell	3,970	$28.72	$114,018.40	38,075

Lauren Riker Buying and Selling Activity at Pacira BioSciences

Pacira BioSciences Company Overview

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

Today's Range

Now: $25.39

$24.43

$25.55

50 Day Range

MA: $23.65

$22.25

$25.55

2 Week Range

Now: $25.39

$18.80

$27.64

Volume

370,497 shs

Average Volume

466,531 shs

Market Capitalization

$999.10 million

P/E Ratio

211.60

Dividend Yield

N/A

Beta

0.27